Evidence map›Paper›PMID 23474082›Full record

ArticleThe American journal of pathology2013

Skp2 deficiency inhibits chemical skin tumorigenesis independent of p27(Kip1) accumulation.

Christopher Sistrunk, Sun Hye Kim, Xian Wang, Sung Hyun Lee, Yongbaek Kim, Everardo Macias, Marcelo L Rodriguez-Puebla

Abstract read
In one paragraph

Article in The American journal of pathology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. A patent review of the ubiquitin ligase system: 2015-2018.Expert opinion on therapeutic patents · 2018
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Roles of F-box proteins in cancer.Nature reviews. Cancer · 2014
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Christopher SistrunkDepartment of Molecular Biomedical Sciences and the Center for Comparative Medicine and Translational Research, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606, USA.
Sun Hye Kim
Xian Wang
Sung Hyun Lee
Yongbaek Kim
Everardo Macias
Marcelo L Rodriguez-Puebla
North Carolina State University · USSeoul National University · KRThe University of Texas at Austin · US

Funding

Roles of Cyclin D3 in Neoplastic ProliferationR01CA116328 · NCI · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI RODRIGUEZ-PUEBLA, MARCELO LUIS · 2006 to 2011
$1.3M
NCI NIH HHS R01 CA116328
6 · The paper itself

Abstract

S-phase kinase-associated protein 2 (Skp2) functions as the receptor component of the Skp-Cullin-F-box complex and is implicated in the degradation of several cell cycle regulators, such as p21(Cip1), p27(Kip1), p57(Kip2), and cyclin E. Numerous studies in human and experimental tumors have demonstrated low p27(Kip1) levels and elevated Skp2 expression. However, a direct association between the inverse correlation of Skp2 and p27(Kip1) with tumorigenesis has not been demonstrated. Herein, we provide evidence that skin tumorigenesis is inhibited in Skp2(-/-) mice. An analysis of mouse keratinocytes indicates that increased p27(Kip1) levels in Skp2(-/-) epidermis cause reduced cell proliferation that is alleviated in the epidermis from Skp2(-/-)/p27(-/-) compound mice. In contrast, we establish that a p27(Kip1) deficiency does not overturn the reduced skin tumorigenesis experienced by Skp2(-/-) mice. In addition, Skp2(-/-) epidermis exhibits an accumulation of p53-cofactor CBP/p300 that is associated with elevated apoptosis in hair follicles and decreased skin tumorigenesis. We conclude that p27(Kip1) accumulation is responsible for the hypoplasia observed in normal tissues of Skp2(-/-) mice but does not have a preponderant function in reducing skin tumorigenesis.

Indexed as

AnimalsApoptosisCarcinogenesisCell CycleCyclin-Dependent Kinase Inhibitor p27EpidermisGene DeletionHumansKineticsMiceMice, Inbred C57BLPapillomaSkin NeoplasmsS-Phase Kinase-Associated ProteinsTumor Suppressor Protein p53Cyclin-Dependent Kinase Inhibitor p27S-Phase Kinase-Associated ProteinsTumor Suppressor Protein p53

Identifiers

PMID23474082
PMCPMC3644727
OpenAlexW2009621185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.